Proqr Thrapeutics N V shs euro shares owned by Citadel Advisors
Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Proqr Thrapeutics N V shs euro
Tip: Access up to 7 years of quarterly data
All positions including Proqr Thrapeutics N V shs euro held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Proqr Thrapeutics N V shs euro by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $169k | 93k | 1.82 |
2024-06-30 | $48k | 29k | 1.66 |
2024-03-31 | $213k | 94k | 2.27 |
2023-12-31 | $204k | 103k | 1.98 |
2023-06-30 | $297k | 184k | 1.62 |
2023-03-31 | $464k | 218k | 2.13 |
2022-12-31 | $376k | 102k | 3.70 |
2022-06-30 | $199k | 256k | 0.78 |
2022-03-31 | $28k | 31k | 0.90 |
2021-12-31 | $2.2M | 271k | 8.02 |
2021-09-30 | $1.8M | 210k | 8.37 |
2021-06-30 | $792k | 118k | 6.73 |
2021-03-31 | $880k | 133k | 6.60 |
2020-12-31 | $68k | 16k | 4.20 |
2020-06-30 | $131k | 22k | 6.06 |
2020-03-31 | $190k | 35k | 5.50 |
2019-09-30 | $380k | 66k | 5.76 |
2019-06-30 | $391k | 43k | 9.09 |
2019-03-31 | $1.1M | 82k | 13.86 |
2018-12-31 | $820k | 52k | 15.77 |
2015-12-31 | $103k | 12k | 8.58 |
2015-09-30 | $198k | 14k | 14.52 |
2015-03-31 | $210k | 9.6k | 21.84 |
2014-09-30 | $1.9M | 109k | 17.19 |
Top funds holding Proqr Thrapeutics N V shs euro
View all funds holding Proqr Thrapeutics N V shs euro